One of the defining characteristics of Michigan Medicine’s Department of Pathology is its commitment to broadly sharing expertise to ensure patients everywhere receive the best care possible. Recently, Pathology faculty, Robert Humble, MD, Rahul Mannan, MD, and Rohit Mehra, MD published an article in Kidney Cancer describing the most recent advances in diagnosing renal neoplasia, including their morphological context, diagnostic algorithm, and available molecular biomarkers to assist pathologists in correctly identifying renal cell carcinomas (RCC) of varying types. In addition, whenever possible, they also provided a brief summary of the current therapeutics that align with each subtype of RCC.
Carl Pierson, PhD, whose decades of service at the University of Michigan left a lasting impact on the field and on those he taught and inspired. Remembered as wise, kind, and forward-thinking, he shaped generations of microbiologists and advanced patient care through innovation and leadership.
Two years ago, a team of Pathology staff embarked on a journey to become culture-change advocates by obtaining FISH! Philosophy Trainer certifications. They received a Wellness grant from Michigan Medicine and began training faculty and staff in the FISH! Philosophy, collecting pre- and post-training data. This team, made up of Melina Adler, Karren Barron, Gloria Barkley, Chris Distelrath, Lynn McCain, and Julene Pummill, supported by Drs. Jeffrey Myers and Kamran Mirza, recently published their data in Laboratory Medicine.
One of the lessons learned through the COVID-19 pandemic, according to Dr. Gabriel Núñez, is that in many situations we can work effectively from anywhere. Originating from Seville, Spain, Núñez, who has been faculty in the Department of Pathology since 1991, has taken this lesson to heart. He purchased a home in Seville and, since 2023, spends the winters there working remotely.
The University of Michigan Medical School is committed to serving those in Michigan and the world, and the faculty in the Department of Pathology live that out daily. One of these faculty is Dr. Gabriel Núñez. Through the years, Núñez has trained researchers from many countries, including nine who are now full professors in Japan. One of these was Dr. Nobuhiko Kamada, who is at the University of Michigan Medical School with a joint appointment at Osaka University in Japan.
Dr. Amir Dehghani Joins the Department of Pathology
One of the most heartbreaking things a parent can hear is “Your child has an aggressive, malignant brain tumor.” When that is followed up with the physician saying there is no effective cure, parents are left devastated. This is what motivates Dr. Sriram Venneti and his research laboratory to dedicate their all to finding a cure. Venneti focuses on Group 3 medulloblastomas, which are very aggressive pediatric brain tumors with no known cure.